pentobarbital will lower the level or impact of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
Decisions regarding the timing of any elective processes demanding anesthesia should choose into consideration the benefits of the treatment weighed versus the possible challenges
pentobarbital will reduce the extent or impact of eltrombopag by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Observe.
pentobarbital will lessen the level or effect of diazepam buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Strong or average CYP3A4 inducers may possibly raise rate of diazepam elimination; hence, efficacy of diazepam may be diminished.
pentobarbital will lower the extent or effect of dexamethasone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will decrease the extent or outcome of amlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the extent or impact of maraviroc by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lessen the level or result of fosamprenavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will decrease the extent or result of etoposide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Avoid coadministration of ganaxolone with reasonable or strong CYP3A4 inducers. If coadministration unavoidable, think about rising ganaxolone dose; even so, usually do not exceed highest day by day dose for weight.
pentobarbital will lower the level or effect of paclitaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.
pentobarbital will reduce the level or result of quinidine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. 戊巴比妥鈉製作 Use Caution/Check.
pentobarbital raises toxicity of methoxyflurane by growing metabolism. Contraindicated. Increased metabolism of methoxyflurane to nephrotoxic compounds.
With therapeutic doses of TCAs, barbiturates boost metabolism and reduce blood concentrations of TCAs.